Valuation Abbott Laboratories

Stocks

Real-time Estimate Cboe BZX 01:02:00 23/10/2026 HKT			5-day change	1st Jan Change
102.21 ^USD	+1.69%		-2.50%	-18.54%

12:54am	Abbott Laboratories' Q3 Somewhat a 'Mixed Bag' With Softened Outlook, Nutrition Spinoff, Oppenheimer Says	MT
12:17am	Abbott Laboratories' 2026 Guidance Cut Driven by Diabetes, Electrophysiology Portfolio, RBC Says	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	241,365	191,427	191,088	196,184	217,859	173,921	-	-
Change	-	-20.69%	-0.18%	2.67%	11.05%	-20.17%	-	-
Enterprise Value (EV) ¹	249,166	198,318	198,871	202,693	222,266	194,853	194,599	190,951
Change	-	-20.41%	0.28%	1.92%	9.66%	-12.33%	-0.13%	-1.87%
P/E	35.7x	28.1x	33.8x	14.8x	33.7x	30x	23.1x	20.3x
PBR	6.93x	5.2x	4.94x	4.11x	4.18x	4.37x	3.49x	3.32x
PEG	-	-36.9x	-2x	0x	-0.7x	-3x	0.8x	1.5x
Capitalization / Revenue	5.6x	4.39x	4.76x	4.68x	4.91x	3.49x	3.23x	3.04x
EV / Revenue	5.78x	4.54x	4.96x	4.83x	5.01x	3.9x	3.61x	3.33x
EV / EBITDA	19.4x	15.9x	19.5x	19.1x	18.9x	15.4x	13.7x	12.4x
EV / EBIT	22x	17.7x	22.3x	21.8x	21.6x	16.7x	15.2x	13.7x
EV / FCF	28.8x	25.4x	39.3x	31.9x	30.1x	25.9x	21.8x	20.1x
FCF Yield	3.47%	3.94%	2.54%	3.13%	3.33%	3.86%	4.58%	4.97%
Dividend per Share ²	1.82	1.92	2.08	2.24	2.4	2.57	2.741	2.898
Rate of return	1.29%	1.75%	1.89%	1.98%	1.92%	2.56%	2.73%	2.88%
EPS ²	3.94	3.91	3.26	7.64	3.72	3.347	4.356	4.96
Distribution rate	46.2%	49.1%	63.8%	29.3%	64.5%	76.8%	62.9%	58.4%
Net sales ¹	43,075	43,653	40,109	41,950	44,328	49,901	53,914	57,285
EBITDA ¹	12,815	12,485	10,188	10,635	11,735	12,648	14,235	15,439
EBIT ¹	11,324	11,231	8,911	9,295	10,301	11,660	12,835	13,959
Net income ¹	7,071	6,933	5,723	13,402	6,524	6,127	7,793	8,643
Net Debt ¹	7,801	6,891	7,783	6,509	4,407	20,933	20,679	17,030
Reference price ²	140.74	109.79	110.07	113.11	125.29	100.51	100.51	100.51
Nbr of stocks (in thousands)	1,714,968	1,743,574	1,736,059	1,734,455	1,738,834	1,730,383	-	-
Announcement Date	26/1/22	25/1/23	24/1/24	22/1/25	22/1/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ABBOTT LABORATORIES	29.59x	3.89x	15.41x	2.56%	174B
STRYKER CORPORATION	23.21x	4.54x	15.84x	1.21%	114B
MEDTRONIC PLC	19.89x	3.46x	12.4x	3.05%	114B
ESSILORLUXOTTICA	30.39x	2.95x	11.92x	2.36%	89.64B
CENCORA, INC.	18.67x	0.21x	13.47x	0.7%	64.96B
HOYA CORPORATION	31.91x	8x	20.56x	1.24%	56.09B
BECTON, DICKINSON AND COMPANY	38.54x	3.57x	12.15x	2.04%	52.94B
IDEXX LABORATORIES, INC.	37.48x	9.31x	26.04x	-.--%	43.6B
ALCON INC.	39.32x	3.19x	11.88x	0.55%	32.77B
MEDLINE INC.	47.44x	1.31x	12.13x	0.21%	30.98B
Average	31.64x	4.04x	15.18x	1.39%	77.29B
Weighted average by Cap.	28.75x	3.96x	14.93x	1.8%